文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Novel Pathological Mechanisms Revealed by Spatial Transcriptomic Analysis of Hippocampus in Aged Control, Primary Age-Related Tauopathy, and Alzheimer's Disease.

作者信息

Deng Hong-Wen, Gong Yun, Zhang Qi-Lei, Wu Di, Liu Anqi, Li Tianying, Xiao Zhengwu, Li Yisu, Haeri Mohammad, Swerdlow Russell, Chen Yiping, Yan Xiaoxin, Shen Hui, Xiao Hong-Mei

出版信息

Res Sq. 2025 Aug 22:rs.3.rs-7303622. doi: 10.21203/rs.3.rs-7303622/v1.


DOI:10.21203/rs.3.rs-7303622/v1
PMID:40894028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393468/
Abstract

While both Primary Age-Related Tauopathy (PART) and Alzheimer's Disease (AD) involve the accumulation of hyperphosphorylated tau (pTau)-positive neurofibrillary tangles (NFTs) in the hippocampus, PART is distinguished by the absence of β-amyloid (Aβ) deposition and is generally associated with milder cognitive impairment than AD. To delineate cellular and molecular mechanisms that are common or uniquely linked to disease progression in PART and AD, we constructed a transcriptome-wide, high-resolution atlas of the human hippocampus using samples from six individuals spanning the aged control (AC), PART, and AD groups. Our results supported that PART represent a precursor stage of AD, as evidenced by the altered transcriptional profiles of excitatory neurons (Exc) in the PART group, which exhibited a markedly increased capacity to promote Aβ production compared to both AC and AD groups. While the microglia (Mic) were reactivated in the PART group, this response was reduced in AD samples despite the presence of Aβ deposition, and appeared to further induce NFTs formation as a loop consequently driving the progression from PART to AD. Furthermore, subregion interactions in the signalling pathways related to neuronal survival and the maintenance of blood-brain-barrier (BBB) integrity were decreasing in the PART and disrupted in the AD groups, compared to the AC group. Additionally, we found a P53 signalling-related gene, , was uniquely upregulated in astrocytes near large vessels in AD. This suggests a potential mechanism of vessel-induced neuronal apoptosis in AD, a feature absent in AC and PART. In summary, our study offers new insights into the relationship between PART and AD, along with the molecular mechanisms driving the transition from PART to AD. Furthermore, we identified key molecular pathways associated with BBB disruption and vascular-associated neuronal degradation in AD which were absent in PART. These findings deepen our understanding of AD pathogenesis and may inform the development of targeted therapeutic strategies.

摘要

相似文献

[1]
Novel Pathological Mechanisms Revealed by Spatial Transcriptomic Analysis of Hippocampus in Aged Control, Primary Age-Related Tauopathy, and Alzheimer's Disease.

Res Sq. 2025-8-22

[2]
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.

IEEE J Transl Eng Health Med. 2025-4-10

[3]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[4]
Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome.

Brain. 2025-7-9

[5]
Co-Aggregation of Syndecan-3 with β-Amyloid Aggravates Neuroinflammation and Cognitive Impairment in 5×FAD Mice.

Int J Mol Sci. 2025-6-8

[6]
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Cochrane Database Syst Rev. 2017-3-22

[7]
The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.

Acta Neuropathol. 2025-6-19

[8]
Hippocampal tau distribution in primary age-related tauopathy: The Vantaa 85+ Study.

Alzheimers Dement. 2025-8

[9]
Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.

Mol Neurodegener. 2022-12-17

[10]
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.

Alzheimers Dement. 2021-4

本文引用的文献

[1]
Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Nat Commun. 2025-5-12

[2]
Mossy fiber expression of αSMA in human hippocampus and its relevance to brain evolution and neuronal development.

Sci Rep. 2025-5-6

[3]
Molecular pathways and diagnosis in spatially resolved Alzheimer's hippocampal atlas.

Neuron. 2025-7-9

[4]
Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer's disease.

Cell Rep. 2025-3-25

[5]
Microglial mechanisms drive amyloid-β clearance in immunized patients with Alzheimer's disease.

Nat Med. 2025-5

[6]
Spatiotemporal analysis of gene expression in the human dentate gyrus reveals age-associated changes in cellular maturation and neuroinflammation.

Cell Rep. 2025-2-18

[7]
Stereo-seq of the prefrontal cortex in aging and Alzheimer's disease.

Nat Commun. 2025-1-8

[8]
KIF5A regulates axonal repair and time-dependent axonal transport of SFPQ granules and mitochondria in human motor neurons.

Neurobiol Dis. 2025-1

[9]
Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer's disease.

Nat Genet. 2024-12

[10]
The role of synaptic protein NSF in the development and progression of neurological diseases.

Front Neurosci. 2024-10-21

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索